He was eating half of what he used to and had lost 20 pounds in the two months hed been on the medication
Image Credit: Alones / Shutterstock In a recent proof-of-concept study published in the journal eClinicalMedicine , researchers in Denmark describe the safety and efficacy outcomes of the first human trial of Dapiglutide, a novel drug that targets both the glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) receptors
The product's neutral taste and smooth texture make it easy to blend into shakes, smoothies, or recipes, offering flexibility for daily nutrition
As a peptide substance, it is highly sensitive to temperature, humidity, and proteases in the gastrointestinal tract
Interventional pain industry: pushing spinal cord stimulators, ablations, injections, and other expensive, and often harmful, procedures